ArticleCell death & disease2021

Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression.

Meng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.